Syncope and the autonomic nervous system

Journal of Cardiovascular Electrophysiology

Volumn 7, Issue 8, 1996, Pages 760-776

  Lurie, Keith G ^a   Benditt, David ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

baroreceptors; central nervous system; heart; mechanoreceptors; tilt table testing; vasovagal syncope

Indexed keywords

ACETYLCHOLINE; ADENOSINE; ADENOSINE TRIPHOSPHATE; ADRENALIN; ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ATENOLOL; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; DISOPYRAMIDE; EDROPHONIUM; FLUDROCORTISONE ACETATE; GLYCERYL TRINITRATE; ISOPRENALINE; METHYSERGIDE; METOPROLOL; NALOXONE; NITROPRUSSIDE SODIUM; OPIATE ANTAGONIST; PINDOLOL; SCOPOLAMINE; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; THEOPHYLLINE;

ALGORITHM; ARTICLE; ARTIFICIAL HEART PACEMAKER; AUTONOMIC NERVOUS SYSTEM; BLOOD VESSEL REACTIVITY; BRADYCARDIA; CENTRAL NERVOUS SYSTEM; CHEMORECEPTOR; HEART ARRHYTHMIA; HEART FUNCTION TEST; HEMODYNAMICS; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MECHANORECEPTOR; NONHUMAN; PHARMACOLOGICAL BLOCKING; PHARMACOLOGICAL STIMULATION; PRESSORECEPTOR; PRIORITY JOURNAL; SYNCOPE; TREATMENT PLANNING;

EID: 0029776003     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.1996.tb00582.x     Document Type: Article

References (123)

1. Savage DD, Corwin L, McGee DL, et al: Epidemiologic features of isolated syncope: The Framingham Study. Stroke 1985;16:626-629.
2. Day SC, Cool EF, Funkenstein H, et al: Evaluation and outcome of emergency room patients with transient loss of consciousness. Am J Med 1982;73:15-23.
3. Kapoor WN, Karpf M, Wieland S, et al: A prospective evaluation and follow-up of patients with syncope. N Engl J Med 1983;309:197-204.
4. Rowell LB: Human Circulation: Regulation During Physical Stress. Oxford University Press, New York, 1986, pp. 137-173.
5. Abboud FM: Special characteristics of the cerebral circulation. Fed Proc 1981;40:2296-2300.
6. Rea RF, Thames MD: Neural control mechanisms and vasovagal syncope. J Cardiovasc Electrophysiol 1993;4:587-595.
7. Abboud FM, Eckberg DL, Johannse UL, et al: Carotid and cardiopulmonary baroreceptor control of splanchnic and forearm vascular resistance during venous pooling in man. J Physiol (Lond) 1979;286:173-184.
8. Abboud FM: Neurocardiogenic syncope. (Editorial Comment) N Engl J Med 1993;328:1117-1120.
9. Abboud FM, Heistad DD, Mark AL, et al: Reflex control of the peripheral circulation. Prog Cardiovasc Dis 1976;18:371-403.
10. White CW, Eckberg DL, Inasaka T, et al: Effects of angiographic contrast media on sino-atrial nodal function. Cardiovasc Res 1976;X:214-223.
11. Somers VK, Zavala DC, Mark AL, et al: Influence of ventilation and hypocapnia on sympathetic nerve responses to hypoxia in normal humans. J Appl Physiol 1989;67:2095-2100.
12. Somers VK, Zavala DC, Mark AL, et al: Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans. J Appl Physiol 1989;67:2101-2106.
13. Somers VK, Kyken ME, Mark AL, et al: Parasympathetic hyperresponsiveness and bradyarrhythmias during apnea in hypertension. Clin Anton Res 1992;2:171-176.
14. Gebber GL, Synder DW: Hypothalamic control of baroreceptor reflexes. Am J Physiol 1970;218:124.
15. McRaven DR, Mark AL, Mayer HE, et al: Responses of coronary vessels to adrenergic stimuli. J Clin Invest 1971;30:773-778.
16. Mark AL, Abboud FM, Schmid PG. et al: Differences in direct effects of adrenergic stimuli in coronary and muscular vessels. J Clin Invest 1972;30:279-284.
17. Abboud FM: Control of the various components of the peripheral vasculature. Fed Proc 1972;31:1226-1239.
18. Abboud FM, Mark AL, Heistad DD, et al: Selectivity of autonomic control of the peripheral circulation in man. Trans Am Clin Climatol Assoc 1975;184-197.
19. Abboud FM, Eckstein JW: Reflex vasoconstrictor and vasodilator responses in man. Circ Res 1966;18/ 19(Suppl 1):96-103.
20. Abboud FM, Eckstein JW: Active reflex vasodilatation in man. Fed Proc 1966;25:111-1617.
21. Pelletier CL, Shepherd JT: Circulatory reflexes from mechanoreceptors in the cardio-aortic area. Circ Res 1973;33:131-138.
22. Donald DE, Shepherd JT: Reflexes from the heart and lungs: Physiological curiosities or important regulatory mechanisms. Cardiovasc Res 1978;12:449-469.
23. Abboud, FM, Thames MD: Interaction of cardiovascular reflexes in circulatory control. In Shepherd JT. Abboud FM, eds: Handbook of Physiology. Section 2: The Cardiovascular System. Peripheral Circulation and Organ Blood Flow. American Physiological Society, Bethesda, 1983, pp. 675-753.
24. Benarroch EE: The central autonomic network. Functional organization, dysfunction, and perspective. Mayo Clin Proc 1993;68:988-1001.
25. Kosinski D, Grubb B, Temesy-Armos P: Pathophysiological aspects of neurocardiogenic syncope: Current concepts and new perspectives. PACE 1995;18:716-724.
26. Kosinski D, Grubb BP, Temesy-Armos P: The use of serotonin reuptake inhibitors in the treatment of neurally mediated cardiovascular disorders. J Serotonin Res 1994;1:85-90.
27. Morgan DA, Thoren P, Wilczynski EA, et al: Serotoninergic mechanisms mediate renal sympathoinhibition during severe hemorrhage in rats. Am J Physiol 1988;255:H496-H502.
28. Miura M, Reis DJ: The role of the solitary and paramedian reticular nucleii in mediating cardiovascular reflex response from carotid baro and chemoreceptors. J Physiol 1972;223:525.
29. Gebber GL, Taylor DG, Weaver LC: Electrophysiological studies on organization of central vasopressor pathways. Am J Physiol 1973;224:470.
30. Rutter PC, Potocnik SJ, Ludbrook J: Sympathoad-renal mechanisms in cardiovascular responses to naloxone after hemorrhage. Am J Physiol 1987;252: H40-H46.
31. Monta H, Nishida Y, Motochigawa H, et al: Opiate receptor-mediated decrease in renal nerve activity during hypotensive hemorrhage in conscious rabbits. Circ Res 1988;63:165-172.
32. Evans RG, Ludbrook J, Potocnik SJ: Intracisternal naloxone and cardiac nerve blockade prevent vasodilatation during simulated hemorrhage in awake rab-bits. J Physiol (Lond) 1989;409:1-14.
33. Smith ML, Carlson MD, Thames MC: Naloxone does not prevent vasovagal syncope during simulated orthostasis in humans. J Auton Nerv Syst 1993;45:1-9.
34. Arnold JM, McDevitt DG: Contribution of the vagus to the hemodynamic responses following intravenous boluses of isoprenaline. Br J Pharmacol 1983;15:423-429.
35. Arnold JM, McDevitt DG: Vagal activity is increased during intravenous isoprenaline infusion in man. Br J Clin Pharmacol 1984;18:311-316.
36. Blair DR, Glover WE, Greenfield AD, et al: Excitation of cholinergic vasodilator nerves to human skeletal muscles during emotional stress. J Physiol 1959; 148:633-647.
37. Goldstein DS, Keiser HR: Pressor and depressor responses after cholinergic blockage in humans. Am Heart J 1984;107:974-979.
38. Goldstein DS, Spanarkel M, Pitterman A, et al: Circulatory control mechanisms in vasodepressor syncope. Am Heart J 1982;104:1071-1075.
39. Benditt DG, Lurie KG, Adler S, et al: Rationale and methodology of head-up tilt table testing for evaluation of neurally-mediated (cardioneurogenic) syncope. In Zipes DP, Jalife J, eds: Cardiac Electrophysiology: From Cell to Bedside. Second Edition. WB Saunders Co., Philadelphia, 1994, pp. 1115-1129.
40. Fitzpatrick AP, Theodorakis G, Vardas P, et al: Methodology of head-up tilt testing in patients with unexplained syncope. J Am Coll Cardiol 1991;17: 125-130.
41. Kenny RA, Bayliss J, Ingram A, et al: Head up tilt: A useful test for investigating unexplained syncope. Lancet 1986;1:1352-1355.
42. Thoren P: Characteristics of left ventricular receptors with nonmyelinated vagal afferent in cats. Circ Res 1977;40:415-421.
43. Donald DE, Shepherd JT: Reflexes from the heart and lungs: Physiological curiosities or important regulatory mechanisms. Cardiovasc Res 1978;12:446-468.
44. Ross RT: Syncope. London, WB Saunders Co., 1988.
45. Khero BA, Mullins CB: Cardiac syncope due to glossopharyngeal neuralgia. Treatment with a transvenous pacemaker. Arch Intern Med 1971;128:806-808.
46. Elam MP, Laird JR, Johnson S, et al: Swallow syncope associated with complete atrioventricular block: A case report and review of the literature. Mil Med 1989;154:465-466.
47. Barcroft H, Edholm OG, McMichael J, et al: Posthaemorrhagic fainting. Lancet 1944;1:489-491.
48. Barcroft H, Edholm OG: On the vasodilatation in human skeletal muscle during posthemorrhagic fainting. J Physiol (Lond) 1945;104:161-175.
49. Fitzpatrick A, Williams T, Jeffrey C, et al: Pathogenic role for arginine vasopressin (AVP) and catecholamines (EP & NEP) in vasovagal syncope. (Abstract) J Am Coll Cardiol 1990;15:98.
50. Remole SC, Neustel M, Bailin S, et al: Adrenal effluent may account for increased norepinephrine levels during tilt-induced syncope. (Abstract) Circulation 1991;84(Supp II):233.
51. Levy MN: Sympathetic-parasympathetic interaction in the heart. Circ Res 1971;29:437-445.
52. Inoue H, Zipes DP: Changes in atrial and ventricular refractoriness and in atrioventricular conduction produced by combination of vagal and sympathetic stimulation that result in a constant spontaneous cycle length. Circ Res 1987;60:942-951.
53. Almquist A, Goldenberg IF, Milstein S, et al: Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. N Engl J Med 1989;320:346-351.
54. Waxman MB, Yao L, Cameron DA, et al: Isoproterenol induction of vasodepressor-type reaction in vasodepressor-prone persons. Am J Cardiol 1989;63: 58-65.
55. Lurie KG, Dutton J, Mangat R, et al: Evaluation of edrophonium as a provocative agent for vasovagal syncope during head-up tilt table testing. Am J Cardiol 1993;72:1286-1290.
56. Wilkins RW, Eichna LW: Blood flow to the forearm and calf. I. Vasoreactions: Role of the sympathetic nervous system. John Hopkins Hosp Bull 1941;68:425-449.
57. Rowell LB: Reflex control of regional circulation in humans. J Auton Nerv Syst 1984;11:101-114.
58. Schadt JC, Ludbrook J: Hemodynamic and neurohumoral responses to acute hypovolemia in conscious mammals. Am J Physiol 1991;260:H305-H318.
59. Ziegler MG, Echon C, Wilnerk D, et al: Sympathetic nervous withdrawal in the vasodepressor (vasovagal) reaction. J Auton Nerv Syst 1986;17:273-278.
60. Johnson JA, Moore WW, Segar WE: Small changes in left atrial pressure and plasma antidiuretic hormone sites in dogs. Am J Physiol 1969;217:210.
61. Brennan LA Jr, Malvin RL, Jochim KE: Influence of right and left atrial receptors in plasma concentrations of ADH and renin. Am J Physiol 1971;221:273.
62. Sander-Jensen K, Secher NH, Astrup A, et al: Hypotension induced by passive head-up tilt: Endocrine and circulatory mechanisms. Am J Physiol 1986;251: R742-R748.
63. Goldsmith SR: Vasopressin as vasopressor. Am J Med 1987;82:1213-1219.
64. Lindner KH, Prengel AW, Pfenninger EG, et al: Vasopressin improves vital organ blood flow during closed-chest cardiopulmonary resuscitation in pigs. Circulation 1994;91:215-221.
65. Lindner KH, Haak T, Keller A, et al: Release of endogenous vasopressors during and after cardiopulmonary resuscitation. Heart 1996;75:145-150.
66. Sander-Jensen K, Garne S, Schwartz TW: Pancreatic polypeptide release during emotionally induced vasovagal syncope. Lancet 1985;2:1132.
67. Unverferth DV, O'Dorisio TM, Muir WW, et al: Effect of vasoactive intestinal polypeptide on the canine cardiovascular system. VIP Cardiovasc Syst 1985; 106:543-550.
68. Levin B, Posner JB: Swallow syncope - Report of a case and review of the literature. Neurology (Minn) 1972;22:1086-1093.
69. Palmer ED: The abnormal upper gastrointestinal vasovagal reflexes that affect the heart. Am J Gastroenterol 1976;66:513-522.
70. Bortolotti M, Cirignotta F, Labo G: Atrioventricular block induced by swallowing with documentation by His bundle recordings. JAMA 1982;248:2297-2299.
71. Armstrong PW, McMillan DG, Simon JB: Swallow syncope. Can Med Assoc J 1985;132:1281-1284.
72. Leitch JW, Klein GJ, Yee R, et al: Syncope associated with supraventricular tachycardia: An expression of tachycardia or vasomotor response. Circulation 1992;85:1064-1071.
73. Schwartz PJ: Idiopathic long QT syndrome: Progress and questions. Am Heart J 1985;109:399-411.
74. Crawford MH, Karliner JS, O'Rourke RA, et al: Prolonged Q-T interval syndrome: Successful treatment with combined ventricular pacing and propranolol. Chest 1975;68:369-371.
75. Eldar M, Griffin JC, Abbott JA, et al: Permanent cardiac pacing in patients with the long QT syndrome. J Am Coll Cardiol 1987;10:600-607.
76. Kleiger RE, Miller JP, Bigger JT, and the Multicenter Post-Infarction Research Group: Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987;59:256-262.
77. Martin GJ, Magid NM, Myers G, et al: Heart rate variability and sudden death secondary to coronary artery disease during ambulatory electrocardiographic monitoring. Am J Cardiol 1987;60:86-89.
78. Bigger TJ Jr, Fleiss JL, Steinman RC, et al: Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992;85:164-171.
79. Kjellgren L, Ip J, Sun K, et al: The role of parasympathetic modulation of the reentrant arrhythmic substrate in the genesis of sustained ventricular tachycardia. PACE 1994;17:1276-1287.
80. Lurie KG, Schwartz JB: Changes in the autonomic nervous system. In Martin A, Camm AJ, eds: Geriatric Cardiology: Principles and Practice. John Wiley & Sons, New York, 1994, pp. 273-288.
81. Diamond MA, Murray RH, Schmid PG: Idiopathic postural hypotension: Physiologic observations and report of a new mode of therapy. J Clin Invest 1970;49:1341.
82. Bannister RF: Clinical feature of autonomic failure: Symptoms, signs, and special investigations. In Bannister R, ed: Autonomic Failure: A Textbook of Clinical Disorders of the Autonomic Nervous System. Second Edition. Oxford University Press, Oxford, 1988, pp. 267-281.
83. Kontos HA, Richardson DW, Norvell JE: Norepinephrine depletion in idiopathic orthostatic hypotension. Ann Intern Med 1975;82:336.
84. Bennett T, Evans D, Hampton JR, et al: Abnormal cardiovascular reflexes in subjects with autonomic neuropathy. J Physiol 1975;246:47P-48P.
85. Hajduczck G, Chapleau MW, Abboud FM: Rapid adaptation of central neurons explains the suppressed baroreflex with aging. Neurobiol Aging 1991;12:601-604.
86. Hajduczck G, Chapleau MW, Johnson SL, et al: Increase in sympathetic activity with age: I. Role of impairment of arterial baroreflexes. Am J Physiol 1991;29(Heart Circ Physiol):H1113-H1120.
87. Hajduczck G, Chapleau MW, Abboud FM: Increase in sympathetic activity with age: II. Role of impairment of cardiopulmonary baroreflexes. Am J Physiol 1991;29(Heart Circ Physiol):H1121-H1127.
88. Lipsitz AL: Syncope in the elderly. Ann Intern Med 1983;99:92-105.
89. Krahn AD, Klein G, Norris C, et al: The etiology of syncope in patients with negative tilt table and electrophysiological testing. Circulation 1995;92:1819-1824.
90. Fleg JL, Asante AVK: Asystole following treadmill exercise in a man without organic heart disease. Arch Intern Med 1983;143:1821-1822.
91. Hirata T, Yano K, Okui T, et al: Asystole with syncope following strenuous exercise in a man without organic heart disease. J Electrocardiol 1987;20:280-283.
92. Kapoor WN: Syncope with abrupt termination of exerase. Am J Med 1989;87:597-599.
93. Sakaguchi S, Shultz JJ, Remole SC, et al: Syncope associated with exercise: A manifestation of neurally mediated syncope. Am J Cardiol 1995;75:476-481.
94. Bristow M, Ginshurg R, Sageman S, et al: Examination of human myocardial heta-adrenergic receptors in congestive heart failure: Evidence for catecholamine subsensitivity due to decreased receptor density. N Engl J Med 1982;307:205-211.
95. Eckherg DL, Drahinsky M. Braunwald E: Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med 1971;285:877.
96. Higgins CB, Vatner SF, Eckherg DL, et al: Alterations in the haroreceptors reflex in conscious dogs with heart failure. J Clin Invest 1972;51:715.
97. Ferguson DW, Abboud FM, Mark AE: Selective impairment of baroreflex mediated vasoconstrictor responses in man in ventricular dysfunction. Circulation 1984;69:451-460.
98. Ahhoud EM: Role of cardiogenic reflexes in heart failure. In Hainsworth R, McWilliam PN, Mary DASG, eds: Cardiogenic Reflexes. Oxford University Press, Oxford, 1987, pp. 371-388.
99. Mark AL, Kioschos JM, Ahhoud RM, et al: Abnormal vascular responses to exercise in patients with aortic stenosis. J Clin Invest 1973;52:1138-1146.
100. Mark AE, Abboud FM, Schmid PG, et al: Reflex vascular responses to left ventricular outflow obstruction and activation of ventricular haroreceptors in dogs. J Clin Invest 1973;52:1147-1153.
101. Brigden W, Sharpey-Schafer EP: Postural changes in peripheral blood flow in cases with left heart failure. Clin Sci 1950:9:93.
102. Raviele A, Gasparini G, DiPede F, et al: Usefulness of head-up tilt test in evaluating patients with syncope of unknown origin and negative electrophysiologic study. Am J Cardiol 1990;65:1322-1327.
103. Benditt DG, Remole S, Bailin S, et al: Tilt table testing for evaluation of neurally-mediated (cardioneurogenic) syncope: Rationale and proposed protocols. PACE 1991;14:1528-1537.
104. Grubb BP, Temesy-Armos P, Hahn H, et al: Utility of upright tilt table testing in the evaluation and management of syncope of unknown origin. Am J Med 1991; 90:6-10.
105. Grubb BP, Wolfe D, Samoil D, et al: Recurrent unexplained syncope in the elderly: The use of head-up-right tilt table testing in evaluation and management. J Am Geriat Soc 1992;40:1123-1128.
106. deMey C; Enterling D: Assessment of the hemodynamic responses to single passive head-up tilt by non-invasive methods in normotensive subjects. Methods Find Exp Clin Pharmacol 1986;8:449-457.
107. Raviele A, Menozzi C, Brignole M, et al: Value of head-up tilt testing potentiated with sublingual nitroglycerin to assess the origin of unexplained syncope. Am J Cardiol 1995;76:267-72.
108. Brignole M, Menozzi C, Alhoni P, et al: The effect of exogenous adenosine in patients with neurally-mediated syncope and sick sinus syndrome. PACE 1994; 17:2211-2216.
109. Calkins H, Kadish A, Sousa J. et al: Comparison of responses to isoproterenol and epinephrine during head-up tilt in suspected vasodepressor syncope. Am J Curdiol 1991;67:207-209.
110. Morillio C, Klein GJ, Zandri S, et al: Diagnostic accuracy of a low dose isoproterenol head up tilt protocol. Am Heart J 1995;129:901-906.
111. Kapoor WN, Brant N: Evaluation of syncope by upright tilt testing with isoproterenol. A nonspecific test. Ann Intern Med 1992;116:358-363.
112. Chen XC, Chen MY, Remole S, et al: Reproducibility of head-up tilt-table testing for eliciting susceptibility to neurally-mediated syncope in patients without structural heart disease. Am J Cardiol 1992;69:755-760.
113. Fish FA, Strasburger JF, Benson DW: Reproducibility of a symptomatic response to upright tilt in young patients with unexplained syncope. Am J Cardiol 1992; 70:605-609.
114. Grubb BP, Wolfe W, Temesy-Armos P, et al: Reproducibility of head upright tilt table test results in patients with syncope. PACE 1992;15:1477-1481.
115. Sheldon R, Splawinski J, Killam S: Reproducibility of upright tilt-table tests in patients with syncope. Am J Cardiol 1992;69:1300-1305.
116. Wieling W, van Lieshout JJ: Investigation and treatment of autonomic circulatory failure. Curr Opin Neurol Neurosurg 1993;6:537-543.
117. Imholz BPM, Wieling W, Langewouters GJ, et al: Continuous finger arterial pressure: Utility in the cardiovascular laboratory. Clin Auton Res 1991;1:43-53.
118. Fitzpatrick A, Sutton R: Tilting towards a diagnosis in unexplained syncope. Lancet 1989;1:658-660.
119. Raviele A, Gasparini G, DiPede F, et al: Nitroglycerin infusion during upright tilt: A new test for the diagnosis of vasovagal syncope. Am Heart J 1994;127:103-111.
120. Lurie KG, Dutton J, Mangat R, et al: Pindolol is effective in patients with vasovagal syncope. PACE 1992;15(Pt II):592.
121. Moya A, Permanyer-Miralda G, Sagrista-Sauleda J. et al: Limitations of head up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: Results of a controlled study of etilefrine versus placebo. J Am Coll Cardiol 1995;25: 65-69.
122. Fitzpatrick AP, Ahmed R, Sutton R: A randomized trial of medical therapy in "malignant vasovagal syndrome" or "neurally-mediated bradycardia/hypotension syndrome." Eur J Card Pacing Electrophysiol 1991;2:99-102.
123. Morillo CA, Leitch LW, Yee R, et al: A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. J Am Coll Cardiol 1993;22:1943-1948.